Recipharm, a contract development and manufacturing organization, headquartered in Jordbro, Sweden, has signed a partnership agreement with Follicum AB in preparation for a clinical trial of the drug candidate FOL-005.

Follicum is a pharmaceutical company based in Lund. Sweden, focused on developing new pharmaceutical treatment for hair loss and unwanted hair growth. Recipharm has been engaged to formulate and produce the product that will be used in the clinical trial. The engagement also includes developing and validating the analytical methods required.

Source: Recipharm